【原美源伯根】Cencora (COR) 2014年年度报告「NYSE」.pdf

《【原美源伯根】Cencora (COR) 2014年年度报告「NYSE」.pdf》由会员分享，可在线阅读，更多相关《【原美源伯根】Cencora (COR) 2014年年度报告「NYSE」.pdf（28页珍藏版）》请在三个皮匠报告上搜索。

1、SummaryAnnualReport201 4 AmerisourceBergenis one of the largest global pharmaceutical sourcing and distribution services companies,helpingboth healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care.With services ranging from drug

2、 distribution and niche premium logistics to reimbursement and pharmaceutical consulting services,AmerisourceBergen delivers innovative programs and solutions across the pharmaceutical supply channel.With over$120 billion in annualized revenue,AmerisourceBergen is headquartered in Valley Forge,PA,an

3、d employs approximately 14,000 people.AmerisourceBergen is ranked#28 on the Fortune 500 list.For more information,please visit .Where knowledge,reach and partnership shape healthcare delivery.Table of ContentsTo Our Stockholderspage 1Global Sourcing and Pharmaceutical Distribution page 6Pharmacy Sol

4、utionspage 8Provider Solutionspage 10Manufacturer Solutionspage 12Corporate and Social Responsibilitypage 14Management Teampage 16Fellow Stockholderspage 17Board of Directorspage 17Financial Statementspage 19In fiscal 2014,we exceeded all ofour financial objectives.Our revenuesfor the full year were

5、 up 36%.Ouradjusted earnings per share were up24%,and we generated free cash flow of$1.2 billion.We made substantialinvestments in our infrastructure,acquired a minority stake in Profarma Distribuidora de ProdutosFarmacuticos S.A.,in Brazil,and alsoinvested in a specialty joint venturewith Profarma.

6、We successfullyrefinanced$500 million of our long-termdebt,and taking both of our sharerepurchase programs together webought back over$750 million of our common stock.As a result of our thoughtful stewardship of theCompanys capital,we enter fiscal 2015with tremendous financial flexibility.Our execut